This inventor holds 15 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Glaxo Group Limited, Astex Therapeutics Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2007-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
13 out of 1,169 
2 out of 126 
2 out of 242 
Years Active: 2007-2019
Title: Brent W. McCleland: Innovator and Inventor in Nrf2 Regulation
Introduction: Brent W. McCleland is a prominent inventor based in King of Prussia, PA, who has made significant contributions to the field of pharmaceutical sciences. With a portfolio of 15 patents, his work primarily focuses on compounds that act as NRF2 regulators, which have the potential to advance therapeutic strategies in medicine.
Latest Patents: Among his notable innovations, Brent's latest patents include two groundbreaking inventions. The first is titled "Biaryl pyrazoles as NRF2 regulators," which encompasses biaryl pyrazole compounds and their pharmaceutical applications. The second, "Arylcyclohexyl pyrazoles as NRF2 regulators," features arylcyclohexyl pyrazole compounds also aimed at NRF2 regulation. These patents signify a commitment to developing compounds that may provide new avenues for treating various diseases.
Career Highlights: Brent's career includes valuable experience working with major companies in the pharmaceutical industry. He has notably contributed to Glaxo Group Limited and GlaxoSmithKline Intellectual Property Development Limited, where his research has laid the groundwork for several significant innovations in drug development.
Collaborations: Throughout his career, Brent has collaborated with several accomplished professionals, including Michael R. Palovich and Dramane Ibrahim Laine. These partnerships have further enriched his research and led to impactful developments in the field.
Conclusion: Brent W. McCleland's work exemplifies the spirit of innovation that drives the pharmaceutical industry forward. With his extensive patent portfolio and collaborative efforts, he continues to contribute to advancements that may improve health outcomes and the effectiveness of therapeutic interventions. His dedication to discovering new NRF2 regulators underscores the crucial role of inventors in shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile